TULIP 10mg Price

Overview

Welcome to Dwaey, specifically on TULIP 10mg Tablets/Film-coated page.
This medicine contains an important and useful components, as it consists of Atorvastatin (as calcium).
TULIP 10mg is available in the market in concentration 10mg/Tablet and in the form of Tablets/Film-coated.

SANDOZ GmbH is the producer of TULIP 10mg and it is imported from AUSTRIA, The most popular alternatives of TULIP 10mg are listed downward .

Mode Of Action

Atorvastatin competitively inhibits HMG-CoA reductase, the enzyme that catalyses the conversion of HMG-CoA to mevalonate. This results in the induction of the LDL receptors and stimulation of LDL catabolism, leading to lowered LDL-cholesterol levels.

Indication

• Primary hypercholesterolemia (heterozygous familial and nonfamilial)
• Mixed Dyslipidemia
• Homozygous familial hypercholesterolemia
• Hypertriglyceridemia
• Familial hypercholesterolemia
• Cardiovascular event prevention
• Primary dysbetalipoproteinemia

Precaution

Patients who consume substantial quantities of alcohol. History of liver disease. Patients with risk factors for myopathy or rhabdomyolysis. Hypothyroidism should be properly managed prior to starting statin therapy. Children <10 yr. Premenarcheal females. Lactation: Because of the potential for adverse reactions in nursing infants, women taking this drug should not breastfeed; contraindicated in nursing mothers.

Side Effects

• >10% Diarrhea (5-14%)
• Nasopharyngitis (4-13%)
• Arthralgia (4-12%) 1-10% Insomnia (1-5%)
• Urinary tract infection (4-8%)
• Nausea (4-7%)
• Dyspepsia (3-6%)
• Increased transaminases (2-3%)
• Muscle spasms (2-5%)
• Musculoskeletal pain (2-5%)
• Myalgia (3-8%)
• Limb pain (3-8%)
• Pharyngolaryngeal pain (1-4%) Frequency Not Defined Angina
• Syncope
• Dyspnea
• Myopathy
• Anaphylaxis
• Stevens-Johnson syndrome
• Myositis Potentially Fatal: Thrombocytopenia. Rhabdomyolysis with acute renal failure.

Contra indication

Hypersensitivity, active liver disease or unexplained persistent elevations of serum transaminase, porphyria, pregnancy, lactation.

Pregnancy and lactation

Pregnancy category: X

Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.